Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP (Q56944772)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 August 2000
edit
Language Label Description Also known as
English
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP
scientific article published on 01 August 2000

    Statements

    Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit